News

Sun Pharma share price falls over 4% after Q4 results. Should you buy, hold or sell?
Sun Pharmaceutical Industries reported a consolidated net profit of ₹2,154 crore in the fourth quarter of FY25, registering a ...
The Financial Express56m
UBS upgrades BEL to ‘Buy’ from ‘Neutral’: Here’s why the defence giant is back in focus
UBS upgrades Bharat Electronics to 'Buy' citing major order growth and proven platforms. Explore why BEL is a stock to watch!